PMID- 21422958
OWN - NLM
STAT- MEDLINE
DCOM- 20110621
LR  - 20221207
IS  - 1537-1948 (Electronic)
IS  - 0025-7079 (Linking)
VI  - 49
IP  - 5
DP  - 2011 May
TI  - Treatment and outcomes for congestive heart failure by race/ethnicity in TRICARE.
PG  - 489-95
LID - 10.1097/MLR.0b013e318207ef87 [doi]
AB  - BACKGROUND: Equitable access to health insurance coverage may improve outcomes of 
      care for chronic health conditions and mitigate racial/ethnic health disparities. 
      This study examines racial/ethnic disparities in the treatment and outcomes of 
      care for TRICARE beneficiaries with congestive heart failure (CHF). METHODS: 
      Using a retrospective cohort analysis, we examined demographic characteristics, 
      sources of care, and comorbid conditions for 2183 beneficiaries of the Military 
      Health System's TRICARE program (representing 115,584 beneficiaries after 
      adjusting for survey weights) with CHF. Treatments included use of CHF-related 
      medications, while the outcome of interest was any CHF-related potentially 
      avoidable hospitalizations (PAHs). RESULTS: While African Americans were less 
      likely than whites to have received beta blockers and angiotensin-converting 
      enzyme inhibitors or angiotensin receptor blockers following a CHF diagnosis 
      (P<0.0001). Hispanics were, in some cases, equally likely as whites to receive 
      pharmacological treatments for CHF. In multivariate models, there were no 
      significant racial/ethnic differences in the odds of a PAH; age greater than 65 
      was the most significant predictor of a PAH. CONCLUSIONS: This study suggests 
      that although there are some racial and ethnic disparities in the receipt of 
      pharmacological therapy for CHF among TRICARE beneficiaries, these differences do 
      not translate into disparities in the likelihood of a PAH. The findings support 
      previous research suggesting that equal access to care may mitigate racial/ethnic 
      health disparities.
FAU - Bagchi, Ann D
AU  - Bagchi AD
AD  - Mathematica Policy Research, 600 Alexander Park, Princeton, NJ 08540, USA. 
      abagchi@mathematica-mpr.com
FAU - Stewart, Kate
AU  - Stewart K
FAU - McLaughlin, Catherine
AU  - McLaughlin C
FAU - Higgins, Patricia
AU  - Higgins P
FAU - Croghan, Thomas
AU  - Croghan T
LA  - eng
PT  - Journal Article
PT  - Research Support, U.S. Gov't, Non-P.H.S.
PL  - United States
TA  - Med Care
JT  - Medical care
JID - 0230027
RN  - 0 (Adrenergic beta-Antagonists)
RN  - 0 (Angiotensin Receptor Antagonists)
RN  - 0 (Angiotensin-Converting Enzyme Inhibitors)
SB  - IM
MH  - Adolescent
MH  - Adrenergic beta-Antagonists/therapeutic use
MH  - Adult
MH  - Black or African American/statistics & numerical data
MH  - Aged
MH  - Angiotensin Receptor Antagonists/therapeutic use
MH  - Angiotensin-Converting Enzyme Inhibitors/therapeutic use
MH  - Ethnicity/*statistics & numerical data
MH  - Female
MH  - Healthcare Disparities/*statistics & numerical data
MH  - Heart Failure/*drug therapy/ethnology
MH  - Hispanic or Latino/statistics & numerical data
MH  - Hospitalization/statistics & numerical data
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - Racial Groups/*statistics & numerical data
MH  - Retrospective Studies
MH  - Treatment Outcome
MH  - White People/statistics & numerical data
MH  - Young Adult
EDAT- 2011/03/23 06:00
MHDA- 2011/06/22 06:00
CRDT- 2011/03/23 06:00
PHST- 2011/03/23 06:00 [entrez]
PHST- 2011/03/23 06:00 [pubmed]
PHST- 2011/06/22 06:00 [medline]
AID - 10.1097/MLR.0b013e318207ef87 [doi]
PST - ppublish
SO  - Med Care. 2011 May;49(5):489-95. doi: 10.1097/MLR.0b013e318207ef87.